Who invested in Point Biopharma?
Point Biopharma's investors include RA Capital Management and Perceptive Advisors.
United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$125Mraised across 1 round since 2022, from 1 source
Point Biopharma's investors include RA Capital Management and Perceptive Advisors.
Point Biopharma has raised $125M across 1 round since 2022.
Point Biopharma's most recent round was an Undisclosed round of $125M in Sept 2022.
Its most recent round, $125M in Sept 2022, is also its largest on record.
Point Biopharma's first round on record, in Sept 2022, was backed by RA Capital Management and Perceptive Advisors.
Point Biopharma's latest named round is an Undisclosed round, in Sept 2022.
Point Biopharma is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.